Author:
Gao Wenwan,Zhou Gang,Li Mei,Wang Pengsen,Li Jungang,Deng Renni
Funder
Technology Innovation and Application Development Project of Chongqing Shapingba District
Joint Medical Research Projects of Chongqing Municipal Health Committee and Chongqing Municipal Science and Technology Bureau
Publisher
Springer Science and Business Media LLC
Reference23 articles.
1. The Joint United Nations Programme on HIV/AIDS, Global HIV. & AIDS statistics—2020 fact sheet [EB/OL]. (2021-01-18). https://www.unaids.org/en/resources/fact-sheet
2. World Health Organization. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach[M]. 2nd ed. Geneva; 2016.
3. Gandhi RT, Bedimo R, Hoy JF, Landovitz RJ, Smith DM, Eaton EF, Lehmann C, Springer SA, Sax PE, Thompson MA, Benson CA, Buchbinder SP, Del Rio C, Eron JJ Jr, Günthard HF, Molina JM, Jacobsen DM, Saag MS. Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2022 recommendations of the international antiviral society-USA panel. JAMA. 2023;329(1):63–84.
4. Chen M, Zhu Q, Xing H, Chen H, Jin X, Dong L, Dai J, Yang M, Yang C, Jia M, Ma Y. The characteristics of pretreatment HIV-1 drug resistance in western Yunnan, China. Epidemiol Infect. 2020;148:e102.
5. Wheeler WH, Ziebell RA, Zabina H, Pieniazek D, Prejean J, Bodnar UR, Mahle KC, Heneine W, Johnson JA, Hall HI. Variant atypical, and resistant HIV surveillance group. prevalence of transmitted drug resistance associated mutations and HIV-1 subtypes in new HIV-1 diagnoses, U.S.-2006. AIDS. 2010;24(8):1203–12.